Examkin

Question

Difficulty: HardClinical Preventive Services and Screening

A 2626-year-old primigravida presents for her first prenatal visit at 88 weeks gestation. Her past medical history is unremarkable, and she takes no medications other than a prenatal vitamin. Initial laboratory results indicate she is Rh-positive and nonimmune to rubella. Arrange the following routine preventive screening tests and immunizations in the correct chronological order from her first trimester through her immediate postpartum period.

  1. 1Obtain a urine culture to screen for asymptomatic bacteriuria
  2. 2Measure maternal serum alpha-fetoprotein (MSAFP) for neural tube defect screening
  3. 3Perform a 5050-g, 11-hour oral glucose challenge test for gestational diabetes
  4. 4Obtain a rectovaginal swab to screen for Group B Streptococcus colonization
  5. 5Administer the measles, mumps, and rubella (MMR) vaccine

Answer

The correct chronological sequence is: 1) Urine culture for asymptomatic bacteriuria (first trimester), 2) Maternal serum alpha-fetoprotein screening (1515-2222 weeks), 3) 5050-g oral glucose challenge test (2424-2828 weeks), 4) Group B Streptococcus rectovaginal swab (3636-3737 weeks), and 5) MMR vaccine (postpartum).
The correct chronological sequence aligns with current USPSTF, ACOG, and CDC/ACIP guidelines for routine prenatal and postpartum preventive care. Asymptomatic bacteriuria is screened at the first prenatal visit to mitigate early risks of ascending infection. MSAFP for neural tube defects is optimally drawn between 1515 and 2222 weeks. Gestational diabetes screening occurs universally between 2424 and 2828 weeks when human placental lactogen heavily drives insulin resistance. Group B Streptococcus screening is performed late in the third trimester (36 0/736\ 0/7 to 37 6/737\ 6/7 weeks) to maximize negative predictive value for intrapartum colonization. Finally, the MMR vaccine is administered in the postpartum period because it is a live-attenuated vaccine and contraindicated during pregnancy.

Step-by-Step Solution

1
Identify the recommended timing for asymptomatic bacteriuria screening.
First prenatal visit (typically first trimester).
USPSTF guidelines strongly recommend early screening (Grade A) to prevent pyelonephritis and associated pregnancy complications.
2
Identify the recommended timing for maternal serum alpha-fetoprotein (MSAFP) testing.
1515 to 2222 weeks gestation.
This is the optimal window for maternal serum screening for fetal open neural tube defects.
3
Identify the recommended timing for gestational diabetes screening in an average-risk patient.
2424 to 2828 weeks gestation.
Universal screening with a 5050-g, 11-hour glucose challenge test is indicated during the late second trimester when placental lactogen heavily drives maternal insulin resistance.
4
Identify the recommended timing for Group B Streptococcus (GBS) screening.
36 0/736\ 0/7 to 37 6/737\ 6/7 weeks gestation.
ACOG recommends universal rectovaginal culture in this precise window to ensure colonization status accurately reflects the patient's status at the onset of labor for targeted intrapartum prophylaxis.
5
Identify the appropriate timing for the MMR vaccine in a rubella-nonimmune pregnant patient.
Immediate postpartum period.
The MMR vaccine is live-attenuated and contraindicated during pregnancy; it must be administered after delivery to confer immunity for future pregnancies without risking fetal infection.

Key Concept

Chronological application of maternal-fetal preventive care guidelines, including first-trimester bacteriuria screening, second-trimester MSAFP and glucose challenge tests, third-trimester GBS screening, and postpartum live-attenuated vaccinations.
Rate this question

Topics

Clinical Preventive Services and Screening

More questions from this topic